0000000000199686

AUTHOR

Giovanna Russo

showing 8 related works from this author

Musculoskeletal manifestations of childhood cancer and differential diagnosis with juvenile idiopathic arthritis (ONCOREUM): a multicentre, cross-sec…

2021

Summary Background Presenting symptoms of childhood cancers might mimic those of rheumatic diseases. However, the evidence available to guide differential diagnosis remains scarce. Preventing wrong or delayed diagnosis is therefore important to avoid incorrect administration of glucocorticoid or immunosuppressive therapy and worsening of prognosis. As such, we aimed to assess the prevalence and characteristics of presenting musculoskeletal manifestations in patients at cancer onset and to identify the factors that differentiate childhood malignancies with arthropathy from juvenile idiopathic arthritis. Methods We did a multicentre, cross-sectional study at 25 paediatric haemato-oncology cen…

medicine.medical_specialtybusiness.industryImmunologyArthritisCancerOdds ratioMusculoskeletal manifestationJuvenile idiopathic arthritismedicine.diseaseHistiocytosisRheumatologySettore MED/38 - PEDIATRIA GENERALE E SPECIALISTICAPrednisoneInternal medicineJoint painArthropathyMusculoskeletal manifestations childhood cancer juvenile idiopathic arthritismedicinechildhood cancerImmunology and AllergyDifferential diagnosismedicine.symptombusinessmedicine.drug
researchProduct

Recombinant erythropoietin vs. blood transfusion care in infants with hereditary spherocytosis: a retrospective cohort study of A.I.E.O.P. patients (…

2017

MalePediatricsmedicine.medical_specialtyBlood transfusionReticulocytesAnemiamedicine.medical_treatmentSpherocytosisSpherocytosisMEDLINEErythrocyte Count; Erythropoietin; Female; Follow-Up Studies; Hemoglobins; Humans; Infant; Infant Newborn; Italy; Male; Recombinant Proteins; Reticulocytes; Retrospective Studies; Spherocytosis Hereditary; Blood Transfusion; HematologyHereditary spherocytosis03 medical and health sciencesHemoglobins0302 clinical medicinemedicineHumansBlood TransfusionRecombinant erythropoietinErythropoietinErythrocyte Count; Erythropoietin; Female; Follow-Up Studies; Hemoglobins; Humans; Infant; Infant Newborn; Italy; Male; Recombinant Proteins; Reticulocytes; Retrospective Studies; Spherocytosis Hereditary; Blood TransfusionRetrospective Studiesbusiness.industryInfantRetrospective cohort studyHematologymedicine.diseaseNewbornRecombinant ProteinsSurgeryHereditaryItalyErythropoietin030220 oncology & carcinogenesisErythrocyte Count030211 gastroenterology & hepatologyFemalebusinessmedicine.drugFollow-Up Studies
researchProduct

Autoimmune neutropenia of infancy: Data from the Italian neutropenia registry

2015

Pediatricsmedicine.medical_specialtybusiness.industryAutoimmune neutropeniamedicineMEDLINEHematologyNeutropeniamedicine.diseasebusinessAmerican Journal of Hematology
researchProduct

Pearson Syndrome: A Retrospective Cohort Study from the Marrow Failure Study Group of A.I.E.O.P. (Associazione Italiana Emato-Oncologia Pediatrica)

2015

Pearson syndrome (PS) is a very rare and often fatal multisystemic mitochondrial disorder involving the liver, kidney, pancreas, and hematopoietic and central nervous system. It is characterized principally by a transfusion-dependent anemia that usually improves over time, a tendency to develop severe infections, and a high mortality rate. We describe a group of 11 PS patients diagnosed in Italy in the period 1993-2014. The analysis of this reasonably sized cohort of patients contributes to the clinical profile of the disease and highlights a rough incidence of 1 case/million newborns. Furthermore, it seems that some biochemical parameters like increased serum alanine and urinary fumaric ac…

Mitochondrial disordersmedicine.medical_specialtyAnemiabusiness.industryUrinary systemMortality rateIncidence (epidemiology)AnemiaRetrospective cohort studyDiseasemedicine.diseaseGastroenterologyArticleSurgeryAnemia; Mitochondrial disorders; Pearson syndromeInternal medicineCohortmedicinePearson syndromebusinessPearson syndrome
researchProduct

Autoimmune neutropenia of childhood secondary to other autoimmune disorders: Data from the Italian neutropenia registry

2017

0301 basic medicinemedicine.medical_specialtyPediatricsHematologybusiness.industryMEDLINEHematologyNeutropeniamedicine.diseaseInfant newborn03 medical and health sciencesDisease susceptibility030104 developmental biology0302 clinical medicineInternal medicineAutoimmune neutropeniamedicinebusiness030215 immunologyAmerican Journal of Hematology
researchProduct

Transfusion Therapy in a Multi-Ethnic Sickle Cell Population Real-World Practice. a Preliminary Data Analysis of Multicentre Survey

2018

Abstract Introduction. Despite the increasing of number of patients with Sickle Cell Disease (SCD) in Italy, due to multi-ethnic migratory phenomena, a large percentage of Caucasian sickle population is already present in Italy mainly with b-thal/HbS genotype. Red cell transfusion is one effective treatment for both acute and chronic complications of SCD, while hydroxycarbamide (HC) is used to reduce the frequency of painful vaso-occlusive crises (VOCs) and decrease the need for blood transfusion. Through the National Comprehensive Reference Centers for SCD, the Italian Society of Thalassemia and Hemoglobinopathies (SITE), in collaboration with the Society Italian Transfusion Medicine and I…

education.field_of_studyPediatricsmedicine.medical_specialtyBlood transfusionAnemiabusiness.industrymedicine.medical_treatmentImmunologyPopulationTransfusion medicineCell BiologyHematology030204 cardiovascular system & hematologymedicine.diseaseBiochemistryAcute chest syndromeSickle cell anemia03 medical and health sciencesRegimen0302 clinical medicine030220 oncology & carcinogenesismedicineTransfusion therapyeducationbusiness
researchProduct

Clinical manifestations and management of four children with Pearson syndrome.

2011

Pearson marrow-pancreas syndrome is a fatal disorder mostly diagnosed during infancy and caused by mutations of mitochondrial DNA. We hereby report on four children affected by Pearson syndrome with hematological disorders at onset. The disease was fatal to three of them and the fourth one, who received hematopoietic stem cell transplantation, died of secondary malignancy. In this latter patient transplantation corrected hematological and non-hematological issues like metabolic acidosis, and we therefore argue that it could be considered as a useful option in an early stage of the disease.

MalePediatricsmedicine.medical_specialtyMitochondrial DiseasesAnemiaMitochondrial diseasemedicine.medical_treatmenttrapianto cellule staminali emopoieticheHematopoietic stem cell transplantationDiseaseDNA MitochondrialLipid Metabolism Inborn Errorsmitochondrial disordersFatal OutcomeMuscular DiseasesCause of Deathhematopoietic stem cell transplantation; mitochondrial disorders; Pearson marrow-pancreas syndrome; trapianto cellule staminali emopoietiche; malattie mitocondriali; sindrome di PearsonGeneticsmedicineCongenital Bone Marrow Failure SyndromesHumansChildGenetics (clinical)Pearson marrow-pancreas syndromeCause of deathPearson syndromebusiness.industryAcyl-CoA Dehydrogenase Long-ChainHematopoietic Stem Cell TransplantationInfantMetabolic acidosissindrome di Pearsonmedicine.diseaseAnemia SideroblasticTransplantationChild PreschoolImmunologymalattie mitocondrialiFemalebusinessGene DeletionAmerican journal of medical genetics. Part A
researchProduct

Idiopathic neutropenia of infancy: Data from the Italian Neutropenia Registry.

2019

Autoimmune neutropenia of infancy (AIN) is characterized by low risk of severe infection, tendency to spontaneously resolve and typically onset at ≤4-5 years of age; it is due to auto-antibodies whose detection is often difficult. In case of negativity of 4 antineutrophils autoantibody tests, after having excluded ethnic, postinfection, drug induced, or congenital neutropenia, according to the Italian guidelines the patients will be defined as affected by "idiopathic neutropenia" (IN). We describe the characteristics of 85 IN patients enrolled in the Italian neutropenia registry: they were compared with 336 children affected by AIN. The 2 groups were clinically very similar and the main dif…

Malemedicine.medical_specialtyNeutropeniaAutoimmunityNeutropeniaDiagnosis Differential03 medical and health sciences0302 clinical medicineSex FactorsMonocytosisRisk FactorsInternal medicineDiagnosismedicineCongenital Bone Marrow Failure SyndromesHumansRegistriesCongenital NeutropeniaHematologyLeukopeniabusiness.industryAge Factors; Autoimmunity; Congenital Bone Marrow Failure Syndromes; Diagnosis Differential; Female; Humans; Infant; Italy; Leukopenia; Male; Neutropenia; Registries; Risk Factors; Sex FactorsAutoantibodyAge FactorsInfantHematologyLeukopeniamedicine.diseaseSettore MED/38Italy030220 oncology & carcinogenesisAutoimmune neutropeniaDifferentialFemalemedicine.symptomDifferential diagnosisbusiness030215 immunologyAmerican journal of hematology
researchProduct